QT Imaging Holdings Inc. Common Stock
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in No… Read more
QT Imaging Holdings Inc. Common Stock (QTI) - Net Assets
Latest net assets as of September 2024: $-9.65 Million USD
Based on the latest financial reports, QT Imaging Holdings Inc. Common Stock (QTI) has net assets worth $-9.65 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.96 Million) and total liabilities ($16.61 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-9.65 Million |
| % of Total Assets | -138.66% |
| Annual Growth Rate | 90.99% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
QT Imaging Holdings Inc. Common Stock - Net Assets Trend (2021–2023)
This chart illustrates how QT Imaging Holdings Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for QT Imaging Holdings Inc. Common Stock (2021–2023)
The table below shows the annual net assets of QT Imaging Holdings Inc. Common Stock from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $10.71 Million | +810.28% |
| 2022-12-31 | $-1.51 Million | -151.31% |
| 2021-12-31 | $2.94 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to QT Imaging Holdings Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1168959400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $23.22 Million | 216.88% |
| Other Components | $4.59 Million | 42.86% |
| Total Equity | $10.71 Million | 100.00% |
QT Imaging Holdings Inc. Common Stock Competitors by Market Cap
The table below lists competitors of QT Imaging Holdings Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
INFORMICA REAL INV
F:IDE
|
$10.73 Million |
|
Outin Futures Co. Ltd
KQ:227610
|
$10.73 Million |
|
Sharc International Systems Inc
OTCQB:INTWF
|
$10.73 Million |
|
Nextedia
PA:ALNXT
|
$10.73 Million |
|
Pact Group Holdings Ltd
PINK:PTTCF
|
$10.72 Million |
|
FarGlory Hotel Co Ltd
TW:2712
|
$10.71 Million |
|
CRYO-CELL INTL DL-01
F:ZCY
|
$10.71 Million |
|
Appasia Bhd
KLSE:0119
|
$10.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QT Imaging Holdings Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -1,507,577 to 10,708,068, a change of 12,215,645.
- Net loss of 5,132,332 reduced equity.
- Share repurchases of 20,277,625 reduced equity.
- Other factors increased equity by 37,625,602.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.13 Million | -47.93% |
| Share Repurchases | $20.28 Million | -189.37% |
| Other Changes | $37.63 Million | +351.38% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares QT Imaging Holdings Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.54x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.35x to 0.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.14 | $0.60 | x |
| 2022-12-31 | $-0.07 | $0.60 | x |
| 2023-12-31 | $1.12 | $0.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently QT Imaging Holdings Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -47.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.19x
- Recent ROE (-47.93%) is above the historical average (-77.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -184.30% | -1482.99% | 0.04x | 2.88x | $-5.71 Million |
| 2022 | 0.00% | -883.32% | 0.09x | 0.00x | $-6.11 Million |
| 2023 | -47.93% | 0.00% | 0.00x | 2.19x | $-6.20 Million |
Industry Comparison
This section compares QT Imaging Holdings Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QT Imaging Holdings Inc. Common Stock (QTI) | $-9.65 Million | -184.30% | N/A | $10.72 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |